Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons

Designer receptors exclusively activated by designer drugs (DREADDs) are an advanced experimental tool that could potentially provide a novel approach to pain management. In particular, expression of an inhibitory (Gi-coupled) DREADD in nociceptors might enable ligand-dependent analgesia. To test th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of neuroscience 2016-10, Vol.36 (42), p.10769-10781
Hauptverfasser: Saloman, Jami L, Scheff, Nicole N, Snyder, Lindsey M, Ross, Sarah E, Davis, Brian M, Gold, Michael S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10781
container_issue 42
container_start_page 10769
container_title The Journal of neuroscience
container_volume 36
creator Saloman, Jami L
Scheff, Nicole N
Snyder, Lindsey M
Ross, Sarah E
Davis, Brian M
Gold, Michael S
description Designer receptors exclusively activated by designer drugs (DREADDs) are an advanced experimental tool that could potentially provide a novel approach to pain management. In particular, expression of an inhibitory (Gi-coupled) DREADD in nociceptors might enable ligand-dependent analgesia. To test this possibility, TRPV1-cre mice were used to restrict expression of Gi-DREADDs to predominantly C-fibers. Whereas baseline heat thresholds in both male and female mice expressing Gi-DREADD were normal, 1 mg/kg clozapine-N-oxide (CNO) produced a significant 3 h increase in heat threshold that returned to baseline by 5 h after injection. Consistent with these behavioral results, CNO decreased action potential firing in isolated sensory neurons from Gi-DREADD mice. Unexpectedly, however, the expression of Gi-DREADD in sensory neurons caused significant changes in voltage-gated Ca and Na currents in the absence of CNO, as well as an increase in Na channel (NaV1.7) expression. Furthermore, CNO-independent excitatory and inhibitory second-messenger signaling was also altered in these mice, which was associated with a decrease in the analgesic effect of endogenous inhibitory G-protein-coupled receptor activation. These results highlight the potential of this exciting technology, but also its limitations, and that it is essential to identify the underlying mechanisms for any observed behavioral phenotypes. DREADD technology is a powerful tool enabling manipulation of activity and/or transmitter release from targeted cell populations. The purpose of this study was to determine whether inhibitory DREADDs in nociceptive afferents could be used to produce analgesia, and if so, how. DREADD activation produced a ligand-dependent analgesia to heat in vivo and a decrease in neuronal firing at the single-cell level. However, we observed that expression of Gi-DREADD also causes ligand-independent changes in ion channel activity and second-messenger signaling. These findings highlight both the potential and the limitations of this exciting technology as well as the necessity to identify the mechanisms underlying any observed phenotype.
doi_str_mv 10.1523/JNEUROSCI.3480-15.2016
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5083007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1834998121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-224b73ccc902ef797253a362490ee8ee23b0af7aecdea7cdf3aeefdde6e7fa113</originalsourceid><addsrcrecordid>eNqNUctu2zAQJIoWiZvmFwIde6ic5UOidClg2E7iwkiCpDkTNLWyWciUSlpJ8xv54lCIY7S3npbgzszu7BByRmFMM8bPf1zPH-5u7qeLMRcFpDQbM6D5BzKK3TJlAuhHMgImIc2FFMfkcwi_AEAClUfkmElZFpSzEXm5tOnsbj6ZzZL5n85jCLZ1iXXJLXrbbdDrJrlG_4ghufVt1Zv4WNq1dlU6ww5dhW6XTJxu1his_pbokDxh0wx1D1tEzDvwondmFwdE0elGu8gZRt2jC61_jnN637rwhXyqdRPwdF9PyMPF_Of0Kl3eXC6mk2VqhJC7lDGxktwYUwLDWpaSZVzznIkSEAtExlega6nRVKilqWquEeuqwhxlrSnlJ-T7m27Xr7ZYmbhgdKs6b7faP6tWW_Vvx9mNWrePKoOCx1NGga97Ad_-7jHs1NYGE91rh20fFC0ykEUODP4DykUZI2HDWvkb1Pg2BI_1YSMKasheHbJXQ_bxTw3ZR-LZ334OtPew-SstBq9T</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834998121</pqid></control><display><type>article</type><title>Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Saloman, Jami L ; Scheff, Nicole N ; Snyder, Lindsey M ; Ross, Sarah E ; Davis, Brian M ; Gold, Michael S</creator><creatorcontrib>Saloman, Jami L ; Scheff, Nicole N ; Snyder, Lindsey M ; Ross, Sarah E ; Davis, Brian M ; Gold, Michael S</creatorcontrib><description>Designer receptors exclusively activated by designer drugs (DREADDs) are an advanced experimental tool that could potentially provide a novel approach to pain management. In particular, expression of an inhibitory (Gi-coupled) DREADD in nociceptors might enable ligand-dependent analgesia. To test this possibility, TRPV1-cre mice were used to restrict expression of Gi-DREADDs to predominantly C-fibers. Whereas baseline heat thresholds in both male and female mice expressing Gi-DREADD were normal, 1 mg/kg clozapine-N-oxide (CNO) produced a significant 3 h increase in heat threshold that returned to baseline by 5 h after injection. Consistent with these behavioral results, CNO decreased action potential firing in isolated sensory neurons from Gi-DREADD mice. Unexpectedly, however, the expression of Gi-DREADD in sensory neurons caused significant changes in voltage-gated Ca and Na currents in the absence of CNO, as well as an increase in Na channel (NaV1.7) expression. Furthermore, CNO-independent excitatory and inhibitory second-messenger signaling was also altered in these mice, which was associated with a decrease in the analgesic effect of endogenous inhibitory G-protein-coupled receptor activation. These results highlight the potential of this exciting technology, but also its limitations, and that it is essential to identify the underlying mechanisms for any observed behavioral phenotypes. DREADD technology is a powerful tool enabling manipulation of activity and/or transmitter release from targeted cell populations. The purpose of this study was to determine whether inhibitory DREADDs in nociceptive afferents could be used to produce analgesia, and if so, how. DREADD activation produced a ligand-dependent analgesia to heat in vivo and a decrease in neuronal firing at the single-cell level. However, we observed that expression of Gi-DREADD also causes ligand-independent changes in ion channel activity and second-messenger signaling. These findings highlight both the potential and the limitations of this exciting technology as well as the necessity to identify the mechanisms underlying any observed phenotype.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/JNEUROSCI.3480-15.2016</identifier><identifier>PMID: 27798132</identifier><language>eng</language><publisher>United States: Society for Neuroscience</publisher><subject>Analgesia ; Animals ; Behavior, Animal - drug effects ; Calcium Channels - drug effects ; Clozapine - pharmacology ; Designer Drugs - pharmacology ; Female ; Male ; Mice ; Nociceptors - drug effects ; Pain Measurement - drug effects ; Pain Threshold - drug effects ; Patch-Clamp Techniques ; Peripheral Nerves - metabolism ; Potassium Channels, Voltage-Gated - drug effects ; Receptors, G-Protein-Coupled - drug effects ; Second Messenger Systems - drug effects ; Sensory Receptor Cells - drug effects ; TRPV Cation Channels - drug effects</subject><ispartof>The Journal of neuroscience, 2016-10, Vol.36 (42), p.10769-10781</ispartof><rights>Copyright © 2016 the authors 0270-6474/16/3610769-13$15.00/0.</rights><rights>Copyright © 2016 the authors 0270-6474/16/3610769-13$15.00/0 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-224b73ccc902ef797253a362490ee8ee23b0af7aecdea7cdf3aeefdde6e7fa113</citedby><cites>FETCH-LOGICAL-c447t-224b73ccc902ef797253a362490ee8ee23b0af7aecdea7cdf3aeefdde6e7fa113</cites><orcidid>0000-0001-6093-6511</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083007/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083007/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27798132$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saloman, Jami L</creatorcontrib><creatorcontrib>Scheff, Nicole N</creatorcontrib><creatorcontrib>Snyder, Lindsey M</creatorcontrib><creatorcontrib>Ross, Sarah E</creatorcontrib><creatorcontrib>Davis, Brian M</creatorcontrib><creatorcontrib>Gold, Michael S</creatorcontrib><title>Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>Designer receptors exclusively activated by designer drugs (DREADDs) are an advanced experimental tool that could potentially provide a novel approach to pain management. In particular, expression of an inhibitory (Gi-coupled) DREADD in nociceptors might enable ligand-dependent analgesia. To test this possibility, TRPV1-cre mice were used to restrict expression of Gi-DREADDs to predominantly C-fibers. Whereas baseline heat thresholds in both male and female mice expressing Gi-DREADD were normal, 1 mg/kg clozapine-N-oxide (CNO) produced a significant 3 h increase in heat threshold that returned to baseline by 5 h after injection. Consistent with these behavioral results, CNO decreased action potential firing in isolated sensory neurons from Gi-DREADD mice. Unexpectedly, however, the expression of Gi-DREADD in sensory neurons caused significant changes in voltage-gated Ca and Na currents in the absence of CNO, as well as an increase in Na channel (NaV1.7) expression. Furthermore, CNO-independent excitatory and inhibitory second-messenger signaling was also altered in these mice, which was associated with a decrease in the analgesic effect of endogenous inhibitory G-protein-coupled receptor activation. These results highlight the potential of this exciting technology, but also its limitations, and that it is essential to identify the underlying mechanisms for any observed behavioral phenotypes. DREADD technology is a powerful tool enabling manipulation of activity and/or transmitter release from targeted cell populations. The purpose of this study was to determine whether inhibitory DREADDs in nociceptive afferents could be used to produce analgesia, and if so, how. DREADD activation produced a ligand-dependent analgesia to heat in vivo and a decrease in neuronal firing at the single-cell level. However, we observed that expression of Gi-DREADD also causes ligand-independent changes in ion channel activity and second-messenger signaling. These findings highlight both the potential and the limitations of this exciting technology as well as the necessity to identify the mechanisms underlying any observed phenotype.</description><subject>Analgesia</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Calcium Channels - drug effects</subject><subject>Clozapine - pharmacology</subject><subject>Designer Drugs - pharmacology</subject><subject>Female</subject><subject>Male</subject><subject>Mice</subject><subject>Nociceptors - drug effects</subject><subject>Pain Measurement - drug effects</subject><subject>Pain Threshold - drug effects</subject><subject>Patch-Clamp Techniques</subject><subject>Peripheral Nerves - metabolism</subject><subject>Potassium Channels, Voltage-Gated - drug effects</subject><subject>Receptors, G-Protein-Coupled - drug effects</subject><subject>Second Messenger Systems - drug effects</subject><subject>Sensory Receptor Cells - drug effects</subject><subject>TRPV Cation Channels - drug effects</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUctu2zAQJIoWiZvmFwIde6ic5UOidClg2E7iwkiCpDkTNLWyWciUSlpJ8xv54lCIY7S3npbgzszu7BByRmFMM8bPf1zPH-5u7qeLMRcFpDQbM6D5BzKK3TJlAuhHMgImIc2FFMfkcwi_AEAClUfkmElZFpSzEXm5tOnsbj6ZzZL5n85jCLZ1iXXJLXrbbdDrJrlG_4ghufVt1Zv4WNq1dlU6ww5dhW6XTJxu1his_pbokDxh0wx1D1tEzDvwondmFwdE0elGu8gZRt2jC61_jnN637rwhXyqdRPwdF9PyMPF_Of0Kl3eXC6mk2VqhJC7lDGxktwYUwLDWpaSZVzznIkSEAtExlega6nRVKilqWquEeuqwhxlrSnlJ-T7m27Xr7ZYmbhgdKs6b7faP6tWW_Vvx9mNWrePKoOCx1NGga97Ad_-7jHs1NYGE91rh20fFC0ykEUODP4DykUZI2HDWvkb1Pg2BI_1YSMKasheHbJXQ_bxTw3ZR-LZ334OtPew-SstBq9T</recordid><startdate>20161019</startdate><enddate>20161019</enddate><creator>Saloman, Jami L</creator><creator>Scheff, Nicole N</creator><creator>Snyder, Lindsey M</creator><creator>Ross, Sarah E</creator><creator>Davis, Brian M</creator><creator>Gold, Michael S</creator><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6093-6511</orcidid></search><sort><creationdate>20161019</creationdate><title>Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons</title><author>Saloman, Jami L ; Scheff, Nicole N ; Snyder, Lindsey M ; Ross, Sarah E ; Davis, Brian M ; Gold, Michael S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-224b73ccc902ef797253a362490ee8ee23b0af7aecdea7cdf3aeefdde6e7fa113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Analgesia</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Calcium Channels - drug effects</topic><topic>Clozapine - pharmacology</topic><topic>Designer Drugs - pharmacology</topic><topic>Female</topic><topic>Male</topic><topic>Mice</topic><topic>Nociceptors - drug effects</topic><topic>Pain Measurement - drug effects</topic><topic>Pain Threshold - drug effects</topic><topic>Patch-Clamp Techniques</topic><topic>Peripheral Nerves - metabolism</topic><topic>Potassium Channels, Voltage-Gated - drug effects</topic><topic>Receptors, G-Protein-Coupled - drug effects</topic><topic>Second Messenger Systems - drug effects</topic><topic>Sensory Receptor Cells - drug effects</topic><topic>TRPV Cation Channels - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saloman, Jami L</creatorcontrib><creatorcontrib>Scheff, Nicole N</creatorcontrib><creatorcontrib>Snyder, Lindsey M</creatorcontrib><creatorcontrib>Ross, Sarah E</creatorcontrib><creatorcontrib>Davis, Brian M</creatorcontrib><creatorcontrib>Gold, Michael S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saloman, Jami L</au><au>Scheff, Nicole N</au><au>Snyder, Lindsey M</au><au>Ross, Sarah E</au><au>Davis, Brian M</au><au>Gold, Michael S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2016-10-19</date><risdate>2016</risdate><volume>36</volume><issue>42</issue><spage>10769</spage><epage>10781</epage><pages>10769-10781</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>Designer receptors exclusively activated by designer drugs (DREADDs) are an advanced experimental tool that could potentially provide a novel approach to pain management. In particular, expression of an inhibitory (Gi-coupled) DREADD in nociceptors might enable ligand-dependent analgesia. To test this possibility, TRPV1-cre mice were used to restrict expression of Gi-DREADDs to predominantly C-fibers. Whereas baseline heat thresholds in both male and female mice expressing Gi-DREADD were normal, 1 mg/kg clozapine-N-oxide (CNO) produced a significant 3 h increase in heat threshold that returned to baseline by 5 h after injection. Consistent with these behavioral results, CNO decreased action potential firing in isolated sensory neurons from Gi-DREADD mice. Unexpectedly, however, the expression of Gi-DREADD in sensory neurons caused significant changes in voltage-gated Ca and Na currents in the absence of CNO, as well as an increase in Na channel (NaV1.7) expression. Furthermore, CNO-independent excitatory and inhibitory second-messenger signaling was also altered in these mice, which was associated with a decrease in the analgesic effect of endogenous inhibitory G-protein-coupled receptor activation. These results highlight the potential of this exciting technology, but also its limitations, and that it is essential to identify the underlying mechanisms for any observed behavioral phenotypes. DREADD technology is a powerful tool enabling manipulation of activity and/or transmitter release from targeted cell populations. The purpose of this study was to determine whether inhibitory DREADDs in nociceptive afferents could be used to produce analgesia, and if so, how. DREADD activation produced a ligand-dependent analgesia to heat in vivo and a decrease in neuronal firing at the single-cell level. However, we observed that expression of Gi-DREADD also causes ligand-independent changes in ion channel activity and second-messenger signaling. These findings highlight both the potential and the limitations of this exciting technology as well as the necessity to identify the mechanisms underlying any observed phenotype.</abstract><cop>United States</cop><pub>Society for Neuroscience</pub><pmid>27798132</pmid><doi>10.1523/JNEUROSCI.3480-15.2016</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-6093-6511</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-6474
ispartof The Journal of neuroscience, 2016-10, Vol.36 (42), p.10769-10781
issn 0270-6474
1529-2401
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5083007
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Analgesia
Animals
Behavior, Animal - drug effects
Calcium Channels - drug effects
Clozapine - pharmacology
Designer Drugs - pharmacology
Female
Male
Mice
Nociceptors - drug effects
Pain Measurement - drug effects
Pain Threshold - drug effects
Patch-Clamp Techniques
Peripheral Nerves - metabolism
Potassium Channels, Voltage-Gated - drug effects
Receptors, G-Protein-Coupled - drug effects
Second Messenger Systems - drug effects
Sensory Receptor Cells - drug effects
TRPV Cation Channels - drug effects
title Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A17%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gi-DREADD%20Expression%20in%20Peripheral%20Nerves%20Produces%20Ligand-Dependent%20Analgesia,%20as%20well%20as%20Ligand-Independent%20Functional%20Changes%20in%20Sensory%20Neurons&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Saloman,%20Jami%20L&rft.date=2016-10-19&rft.volume=36&rft.issue=42&rft.spage=10769&rft.epage=10781&rft.pages=10769-10781&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/JNEUROSCI.3480-15.2016&rft_dat=%3Cproquest_pubme%3E1834998121%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834998121&rft_id=info:pmid/27798132&rfr_iscdi=true